Lantern Pharma Inc. (NASDAQ: LTRN) reported that a patient with diffuse large B-cell lymphoma achieved complete metabolic response in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE